. Author manuscript; available in PMC: 2014 Nov 14.

Published in final edited form as: J Diabetes Complications. 2014 Jan 21;28(3):399–405. doi: 10.1016/j.jdiacomp.2014.01.009

Table 2. Pearson’s correlation coefficient showing relationship between decreases in systolic blood pressure (SBP) and body weight.

Data are last observation carried forward for the intention-to-treat population.

Treatment	Week	Least squares means of change in SBP (mmHg)	Least squares means of change in body weight (kg)	Pearson’s correlation between change in SBP and change in body weight	P value of Pearson’s correlation between change in SBP and change in body weight
Liraglutide 1.2 mg	2	−3.11	−0.94	0.0823	0.0148
	26	−2.67	−1.19	0.0920	0.0063
Liraglutide 1.8 mg	2	−2.97	−0.96	0.1084	0.0001
	26	−2.91	−1.78	0.1208	<0.0001
Placebo	2	−0.63	−0.19	0.0428	0.3305
	26	−0.53	−0.52	0.0923	0.0355